Luye Financial Statements From 2010 to 2024
| LYPHF Stock | USD 0.34 0.03 9.68% |
Check Luye Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Luye Pharma's main balance sheet or income statement drivers, such as , as well as many indicators such as . Luye financial statements analysis is a perfect complement when working with Luye Pharma Valuation or Volatility modules.
Luye |
Luye Pharma Group Company Return On Asset Analysis
Luye Pharma's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Luye Pharma Return On Asset | 0.0081 |
Most of Luye Pharma's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Luye Pharma Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Luye Pharma Group has a Return On Asset of 0.0081. This is 100.09% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The return on asset for all United States stocks is 105.79% lower than that of the firm.
Luye Pharma Group Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Luye Pharma's current stock value. Our valuation model uses many indicators to compare Luye Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Luye Pharma competition to find correlations between indicators driving Luye Pharma's intrinsic value. More Info.Luye Pharma Group is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Luye Pharma's earnings, one of the primary drivers of an investment's value.About Luye Pharma Financial Statements
Luye Pharma stakeholders use historical fundamental indicators, such as Luye Pharma's revenue or net income, to determine how well the company is positioned to perform in the future. Although Luye Pharma investors may analyze each financial statement separately, they are all interrelated. For example, changes in Luye Pharma's assets and liabilities are reflected in the revenues and expenses on Luye Pharma's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Luye Pharma Group. Please read more on our technical analysis and fundamental analysis pages.
Luye Pharma Group Ltd. develops, produces, markets, and sells pharmaceutical products worldwide. The company was founded in 1994 and is headquartered in Yantai, the Peoples Republic of China. Luye Pharma is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Luye Pink Sheet
Luye Pharma financial ratios help investors to determine whether Luye Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Luye with respect to the benefits of owning Luye Pharma security.